DarioHealth, a digital chronic-condition-management platform, reported $3.6 million in revenue for Q4 2023, compared to $6.8 million for the fourth quarter of 2022, a 47% decrease. Year-over-year revenue in 2023 was $20.4 million, compared to $27.7 million for 2022.
The New York-based company said the overall decrease in revenue stemmed from lower consumer and strategic-partner channels.
The...
DarioHealth, a digital chronic condition management platform, announced that Eitan Shay is joining the company in the newly created position of chief product officer. Shay was previously in leadership roles at Livongo, Teladoc Health and Meta.
Arnaud Robert is also joining Dario as a strategic advisor to the company's CEO, Erez Raphael. Robert recently served as executive vice president and...
Telehealth company Amwell is partnering with digital chronic condition management platform DarioHealth to add a cardiometabolic program to its suite of digital offerings.
Under the partnership, patients who receive care from clinicians using Amwell's telehealth platform can be referred to Dario's program for chronic conditions like diabetes, high blood pressure and weight management.
The digital...
DarioHealth is partnering with Dexcom to integrate the company's continuous glucose monitors into Dario's chronic-condition management platform.
The collaboration will allow Dario's digital health tools for metabolic health to include data from Dexcom CGMs, wearable sensors that automatically monitor blood glucose levels for patients with diabetes.
Dario said integrating CGM data would provide...
French multinational pharmaceutical and healthcare company Sanofi announced a partnership with New York-based TrialSpark, which offers a technology-based model for drug development.
TrialSpark's tools aim for more efficient trial design, faster trial completion and higher quality trial data. It acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them using its...
Home and community value-based care startup CareBridge scooped up $140 million in a new funding round led by Oak HC/FT, bringing its valuation to more than $1 billion.
The company, which focuses on Medicaid and dual eligible patients with disabilities using at-home care, offers electronic visit verification and data aggravation services, and virtual support from care teams.
CareBridge will use...
Digital chronic condition management company DarioHealth posted a net loss of $15.9 million in the first quarter, slightly higher than the $15 million net loss from Q1 last year. But the company beat its revenue expectations with $8.06 million, a 124% increase from last year.
Total operating expenses were $19.9 million, compared with $15.4 million in Q1 2021 and $22.2 million during the fourth...
Digital chronic condition management company DarioHealth has entered into a $30 million strategic partnership with biopharma giant Sanofi to speed adoption of Dario's suite of tools in the U.S.
The agreement with the multinational pharma company's U.S. division will focus on "significantly" expanding Dario's sales to health plans and to select employers. The deal also allows the companies to...
Musculoskeletal care is a big problem for the U.S. healthcare system, digital health companies say. Disorders are common and expensive to treat, but care that could cut down those high costs is inaccessible to many who need it.
That message is resonating with investors. Over the past year, they've poured hundreds of millions of dollars into the digital MSK space. Unicorns Hinge Health and SWORD...
Digital chronic condition management company DarioHealth announced Thursday it had entered into an agreement to acquire Physimax, a company that offers AI-enabled movement assessment and injury prevention.
The deal, which needs regulatory approval from the Israel Innovation Authority before it closes, will cost Dario up to 256,660 shares of its common stock and a cash payment of $500,000. The...